foto london banner.jpg

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Management to investors: the communicative conundr...

We have published our annual investor perception survey, confirming or disp...

Read More

Investorview – Precision Investing with Jay Goth, ...

Our latest investorview is, this week, with Jay Goth, Managing Partner of t...

Read More

Investorview – Zishan Haroon, Chairman & General P...

In a new regular feature for Drugs & Dealers, we’ll be interviewing some of...

Read More

What is Medtech?

Medtech is a very broad sector – it covers any technology that can be used ...

Read More

Investor interview with Mark Barnett

Biotech and Money recently caught up with Mark Barnett, Head of UK Equities...

Read More

Francois Martelet, CEO and his aim for NetScientif...

3 months into his tenure as CEO of NetScientific, the vastly experienced in...

Read More

Attracting investment from a leading EIS fund

We talk to CEO David Venables off the back of Synpromics securing £2.1m EIS...

Read More

Using conformational design to target a $9bn thera...

C4X Discovery, a Manchester-based, AIM-listed Company which uses an NMR-bas...

Read More

Investing in making the undruggable druggable

PhoreMost Ltd, a biopharmaceutical company focused on increasing the divers...

Read More

How one cell therapy company is driving a paradigm...

What you will learn by reading this post: How Ajan Reginald, CEO, Cell Ther...

Read More

5 unique insights from the man at the helm of UK l...

Imperial Innovations has recently released its HY results, and I had the op...

Read More

ISSUE 5, 2015 Drugs & Dealers Magazine Released

Biotech and Money are pleased to announce the release of the latest Drugs &...

Read More

Add Your Response